Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM.

Quezado M, Ronchetti R, Rapkiewicz A, Santi M, Blumenthal DT, Rushing EJ.

Clin Neuropathol. 2005 Jul-Aug;24(4):163-9.

PMID:
16033132
2.

Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?

Burger PC, Pearl DK, Aldape K, Yates AJ, Scheithauer BW, Passe SM, Jenkins RB, James CD.

J Neuropathol Exp Neurol. 2001 Nov;60(11):1099-104.

3.
5.

Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH).

Fischer I, de la Cruz C, Rivera AL, Aldape K.

Diagn Mol Pathol. 2008 Dec;17(4):227-30. doi: 10.1097/PDM.0b013e3181642230.

PMID:
18382350
6.

Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.

Sholl LM, John Iafrate A, Chou YP, Wu MT, Goan YG, Su L, Huang YT, Christiani DC, Chirieac LR.

Mod Pathol. 2007 Oct;20(10):1028-35. Epub 2007 Aug 3.

7.

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M, Nakamura H, Makino K, Saya H, Hirano H, Kuratsu J, Oka K, Ishimaru Y, Ushio Y.

Cancer Res. 2003 Oct 15;63(20):6962-70.

8.

Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.

Quan AL, Barnett GH, Lee SY, Vogelbaum MA, Toms SA, Staugaitis SM, Prayson RA, Peereboom DM, Stevens GH, Cohen BH, Suh JH.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):695-703. Epub 2005 Jun 2.

PMID:
15936158
9.

Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.

Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS.

Clin Cancer Res. 2002 Sep;8(9):2894-901.

10.

Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.

Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA, Callaghan R, Benito R, Roldan P, Piquer J, Llacer J, Barbera J.

Clin Neuropathol. 2005 Sep-Oct;24(5):209-18.

PMID:
16167544
11.

Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization study.

Yoo SB, Lee HJ, Park JO, Choe G, Chung DH, Seo JW, Chung JH.

Lung Cancer. 2010 Mar;67(3):301-5. doi: 10.1016/j.lungcan.2009.05.002. Epub 2009 Jun 7.

PMID:
19505745
12.

Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma.

Toth J, Egervari K, Klekner A, Bognar L, Szanto J, Nemes Z, Szollosi Z.

Pathol Oncol Res. 2009 Jun;15(2):225-9. doi: 10.1007/s12253-008-9082-4. Epub 2008 Aug 28.

PMID:
18752056
13.
14.

The EGFRvIII variant in glioblastoma multiforme.

Gan HK, Kaye AH, Luwor RB.

J Clin Neurosci. 2009 Jun;16(6):748-54. doi: 10.1016/j.jocn.2008.12.005. Epub 2009 Mar 25. Review.

PMID:
19324552
15.

Comparison of automated silver enhanced in situ hybridization and fluorescence in situ hybridization for evaluation of epidermal growth factor receptor status in human glioblastomas.

Gaiser T, Waha A, Moessler F, Bruckner T, Pietsch T, von Deimling A.

Mod Pathol. 2009 Sep;22(9):1263-71. doi: 10.1038/modpathol.2009.86. Epub 2009 Jun 12.

16.
17.

Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.

Viana-Pereira M, Lopes JM, Little S, Milanezi F, Basto D, Pardal F, Jones C, Reis RM.

Anticancer Res. 2008 Mar-Apr;28(2A):913-20.

18.

Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme.

Stockhausen MT, Broholm H, Villingshøj M, Kirchhoff M, Gerdes T, Kristoffersen K, Kosteljanetz M, Spang-Thomsen M, Poulsen HS.

Exp Cell Res. 2011 Jul 1;317(11):1513-26. doi: 10.1016/j.yexcr.2011.04.001. Epub 2011 Apr 15.

PMID:
21514294
19.

Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.

Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, Moran MF, Guha A.

Cancer Res. 2009 Oct 1;69(19):7548-56. doi: 10.1158/0008-5472.CAN-08-4783. Epub 2009 Sep 22.

20.

Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme.

Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN, von Deimling A.

Brain Pathol. 1997 Jul;7(3):871-5.

PMID:
9217972
Items per page

Supplemental Content

Write to the Help Desk